Journal of Medical Economics, Volume 23, Issue 5 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 23, Issue 5 (2020)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Volume 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Oncology

Article
A population-based study of the humanistic burden among cancer patients in Japan
Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki, Naoki Matsumaru & Katsura Tsukamoto
Pages: 429-441
Published online: 31 Dec 2019
AbstractforA population-based study of the humanistic burden among cancer patients in Japan | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 2033 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States
Robert Haddad, Ezra E.W. Cohen, Meena Venkatachalam, Kate Young, Prianka Singh, James W. Shaw, Beata Korytowsky, Pranav Abraham & Kevin J. Harrington
Pages: 442-447
Published online: 29 Jan 2020
AbstractforCost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States | Full Text | References | PDF (786.3 KB) | EPUB | Supplemental
  • 3350 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of FOLFIRI + cetuximab vs FOLFIRI + bevacizumab in the first-line treatment of RAS wild-type metastatic colorectal cancer in Germany: data from the FIRE-3 (AIO KRK-0306) study
Sebastian Stintzing, Ilse van Oostrum, Chris P. Pescott, Philippe Ronga, Bart Heeg & Volker Heinemann
Pages: 448-455
Published online: 17 Jan 2020
AbstractforCost-effectiveness of FOLFIRI + cetuximab vs FOLFIRI + bevacizumab in the first-line treatment of RAS wild-type metastatic colorectal cancer in Germany: data from the FIRE-3 (AIO KRK-0306) study | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 3964 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Article
Treatment patterns and direct medical costs of metastatic colorectal cancer patients: a retrospective study of electronic medical records from urban China
Lin Shen, Qi Li, Wei Wang, Lingjun Zhu, Qingchuan Zhao, Yongzhan Nie, Bo Zhu, Dong Ma, Xiaoyan Lin, Xiaohong Cai, Weijia Fang, Cike Peng, Yun Chen, Honghao Fang, Zheng Yin, Hongyan Li, Ning Wang & Ruihua Xu
Pages: 456-463
Published online: 13 Feb 2020
AbstractforTreatment patterns and direct medical costs of metastatic colorectal cancer patients: a retrospective study of electronic medical records from urban China | Full Text | References | PDF (1.2 MB) | EPUB
  • 2609 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of atezolizumab versus docetaxel and nivolumab in the treatment of non-small cell lung cancer as a second line in France
Sivignon Marine, Roze Stéphane, Plommet Nicolas, Federico Felizzi, Noman Paracha, Mazaleyrat Benjamin & Maurice Perol
Pages: 464-473
Published online: 13 Feb 2020
AbstractforCost-effectiveness of atezolizumab versus docetaxel and nivolumab in the treatment of non-small cell lung cancer as a second line in France | Full Text | References | PDF (1.1 MB) | EPUB
  • 5120 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access

Neurology

Article
Modeling the impact of patient treatment preference on health outcomes in relapsing-remitting multiple sclerosis
Emma van Eijndhoven, Michelle Brauer, Rebecca Kee, Joanna MacEwan, Lisa Mucha, Schiffon L. Wong, Adeline Durand & Jason Shafrin
Pages: 474-483
Published online: 21 Jan 2020
AbstractforModeling the impact of patient treatment preference on health outcomes in relapsing-remitting multiple sclerosis | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 2877 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of cladribine tablets versus fingolimod in patients with highly active relapsing multiple sclerosis in Portugal
Bernardete Pinheiro, Rita Guerreiro, João Costa & Luís Silva Miguel
Pages: 484-491
Published online: 10 Feb 2020
AbstractforCost-effectiveness of cladribine tablets versus fingolimod in patients with highly active relapsing multiple sclerosis in Portugal | Full Text | References | PDF (1 MB) | EPUB
  • 2674 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access

Respiratory Medicine

Article
Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain
Antoni Sicras-Mainar, Margarita Capel, Ruth Navarro-Artieda, Javier Nuevo, Marcos Orellana & Gustavo Resler
Pages: 492-500
Published online: 06 Feb 2020
AbstractforReal-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain | Full Text | References | PDF (1.1 MB) | EPUB
  • 3041 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access

Genetic Disease

Article
Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia A
Keziah Cook, Shaun P. Forbes, Kelly Adamski, Janice J. Ma, Anita Chawla & Louis P. Garrison Jr.
Pages: 501-512
Published online: 13 Feb 2020
AbstractforAssessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia A | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 10015 Views
  • 30 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular

Article
Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis
Corinne Emery, Elodie Torreton, Jean-Baptiste Briere, Thomas Evers & Francis Fagnani
Pages: 513-520
Published online: 25 Jan 2020
AbstractforEconomic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis | Full Text | References | PDF (707.9 KB) | EPUB
  • 1586 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
The economic impact of clinically significant tricuspid regurgitation in a large, administrative claims database
David P. Cork, Peter A. McCullough, Hirsch S. Mehta, Colin M. Barker, Joanna Van Houten, Candace Gunnarsson, Michael P. Ryan, Erin R. Baker, Sarah Mollenkopf & Patrick Verta
Pages: 521-528
Published online: 02 Mar 2020
AbstractforThe economic impact of clinically significant tricuspid regurgitation in a large, administrative claims database | Full Text | References | PDF (952.7 KB) | EPUB | Supplemental
  • 922 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Pain Management

Article
Cost-effectiveness of mirogabalin for the treatment of post-herpetic neuralgia in Taiwan
Xin Ye, Emma Gray, Yen-Feng Wang & Shuu-Jiun Wang
Pages: 529-536
Published online: 19 Feb 2020
AbstractforCost-effectiveness of mirogabalin for the treatment of post-herpetic neuralgia in Taiwan | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 2788 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Explore articles